No Detail Found!

Clinical and Laboratory Profiling of Chronic Hepatitis B Virus Patients

Author(s)
Aws Z. Abdulkareem Science Department, College of Basic Education, University of Diyala, Iraq
Tamara Amer Taha Science Department, College of Basic Education, University of Diyala, Iraq
Ammar Adnan Tuama Science Department, College of Basic Education, University of Diyala, Iraq
Abstract
Background: Hepatitis B virus (HBV) infection remains an important public health issue globally. This is especially true for underdeveloped countries. To establish effective preventative and containment measures and strategies, it is important to know the age-specific distribution of HBV infection. This study aimed to analyse the age-specific distribution of hepatitis B virus infection, using the hepatitis B surface antigen (HBsAg) presence as an indicator. Materials and Procedures: Eighty serum samples from various ages and people were collected. Conventional serological techniques were used to test samples for HBsAg. The chi-square (?²) test was used to statistically analyze the relationship between age-specific groups and HBsAg-positive cases. Findings: Age was statistically significantly correlated with HBsAg positivity (?² = 9.182, p<0.01). The highest positive rates were found among 21- to 30-year-olds (29.09%), which was followed by those 41-50 years old (10.90%) and 31-40 years old (10%). In contrast, positive children (1-12 years) and adolescents (13-20) were very low (0.90%). Thus, 21-30-year-olds contributed significantly to the overall prevalence of HBV (p<0.01). In conclusion, it was found that infection is closely related to age, with the most common occurring in young adults. On the other hand, while the rise in adult occurrence emphasises the need for targeted screening, improved control of infection and public health awareness to reduce infections, the decline in this age group shows that immunity from hepatitis-B vaccine programmes has been effective.
Publication Details
Page(s) 177-181
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 1, Year: 2026

Request the full text from PASTIC

Keywords
Laboratory profile, Hepatitis B virus, Clinical profile, HBsAg, Anti-HBc, liver function tests, Chronic hepatitis B
References
Li D. .2020 .Diagnostic accuracy of ELISA in clinical laboratory testing. , 11 : 1786.
Tuaillon E. . .Comparison of serological assays for disease detection. ” Clinical Microbiology Reviews, 35(2022) : e00085-21.
.2023 .Laboratory testing strategies and diagnostic accuracy of immunoassays. ” WHO Technical Report Series, : .
Otto M. .2020 .Staphylococcus haemolyticus: A major player in the emergence of multidrug-resistant staphylococci. ” Future Microbiology, 15 : 637-650.
Becker K. . .Coagulase-negative staphylococci. ” Clinical Microbiology Reviews, 27(2014) : 870-926.
Cui L. .2021 .Quorum sensing systems and biofilm formation in coagulase-negative staphylococci. , 12 : 659196.
Ponnanikajamideen M. .2020 .Anti-biofilm activity of metal oxide nanoparticles against pathogenic bacteria. ” Journal of Photochemistry and Photobiology B, 210 : 111989.
Elkodous Abd,M. Abd . .Green synthesis of nanoparticles: Applications and limitations. Nanotechnology Reviews, 9(2020) : 182-213.
Ahmed S. .2021 .Green synthesis of metal oxide nanoparticles using plant extracts and their antimicrobial applications. ” Biotechnology Reports, 30 : e00664.
Al-Khafaji Z.M.,Al-Saadi M.A.K. . .Biofilm formation and antimicrobial resistance among coagulase-negative staphylococci isolated from urinary tract infections. Iranian Journal of Microbiology, 13(2021) : 310-318.
Khashan K.S. . .Antibacterial activity of magnesium oxide nanoparticles against multidrug-resistant bacteria. ” Materials Research Express, 7(2020) : 015084.
Mahmoudi S. .2021 .The agr quorum-sensing system and its role in staphylococcal virulence regulation. ” Microbial Pathogenesis, 158 : 105084.
Al-Zubaidi A.F . .Biofilm formation and virulence gene expression in multidrug-resistant staphylococci isolated from clinical samples. ” Microbes and Infectious Diseases, 4(2023) : 345-354.
.2017 .Global priority list of antibioticresistant bacteria. , : .
.2016 .Global health sector strategy on viral hepatitis 2016-2021. , : .
Roudot-Thoraval F. .2021 .Epidemiology of hepatitis C virus infection. ” Clinical Research in Hepatology and Gastroenterology, 45 : 101596.
Lewis K.C. .2023 .” Clinical Infectious Diseases. , 77 : 1413-1415.
Messina V. . .Hepatitis C virus micro-elimination in the hospital setting: The results of the HCV Caserta hospital project. ” Journal of Infection and Public Health, 15(2022) : 562-565.
Clinical Chemistry . .. , 66(2020) : 282-287.
.2023 .” Clinical Infectious Diseases. , 77 : 1413-1415.
Zou B. .1999 .Prevalence of viremic hepatitis C virus infection by age, race/ethnicity, and birthplace and disease awareness among viremic persons in the United States,. ” Journal of Infectious Diseases, 221(2020) : 408-418.
Singh P. .2022 .Biological synthesis of nanoparticles and their role in biofilm inhibition. ” Colloids and Surfaces B: Biointerfaces, 215 : 112522.
0

Citations

0

Downloads

15

Views